ProsTAV Genetic Test
The ProsTAV Genetic Test is a molecular diagnostic tool designed to assess the risk of prostate cancer progression through the analysis of specific genetic biomarkers.
This test studies the expression of certain genes associated with tumor aggressiveness and disease evolution, enabling specialists to make more precise decisions regarding treatment and patient follow-up.
What is it used for?
It is mainly used in patients with suspected or diagnosed prostate cancer in different clinical scenarios:
- Risk assessment in men with elevated PSA levels and suspected prostate cancer.
- Prognosis after diagnosis in order to determine tumor aggressiveness and define whether immediate treatment or active surveillance is needed.
- Selection of the most appropriate treatment, helping differentiate between options such as surgery, radiotherapy, or conservative management.
- Monitoring disease progression in patients already diagnosed and treated.
Main benefits
- Greater precision in risk stratification → Differentiates between aggressive prostate cancers and slow-growing ones, reducing unnecessary treatments.
- Avoids unnecessary biopsies → In some cases, it may help avoid invasive procedures if the risk is low.
- Treatment optimization → Personalizes the therapeutic approach based on tumor biology, improving treatment effectiveness.
- More peace of mind for the patient → By providing more detailed prognostic information, it allows for informed decision-making with the specialist.